If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
1
Followers on Owler
DyNAbind
develops a SaaS-based platform that provides DNA-encoded libraries and fragment-based drug discovery solutions to the healthcare sector...
Read more
Overview
Competitors
Funding
News & Insights
DyNAbind
develops a SaaS-based platform that provides DNA-encoded libraries and fragment-based drug discovery solutions to the healthcare sector...
Read more
Co-Founder & CEO
Michael Thompson
CEO Approval Rating
90/100
Weigh In
2017
Dresden
Hamburg
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
https://dynabind.com/
Est. Annual Revenue
$100K-5.0M
Agree?
Yes
No
Est. Employees
1-25
Agree?
Yes
No
News
Latest News
May 09, 2023
FinanzNachrichten
DyNAbind: Salipro Biotech AB: Salipro Biotech and DyNAbind Announce Milestone Achievement in Collaboration to Enable DEL for Membrane Proteins
Jul 05, 2019
Pharmabiz
DyNAbind: Confo Therapeutics, DyNAbind ink drug discovery collaboration to identify novel GPCR─modulating compounds
Jul 03, 2019
The Pharma Letter
DyNAbind: Another collaboration for Belgian biotech Confo Therapeutics
Follow and Get Alerts
DyNAbind Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 27 + competitors
Trending Companies